Sysmex Corp
TSE:6869

Watchlist Manager
Sysmex Corp Logo
Sysmex Corp
TSE:6869
Watchlist
Price: 3 177 JPY 1.44% Market Closed
Market Cap: 2T JPY
Have any thoughts about
Sysmex Corp?
Write Note

Sysmex Corp
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sysmex Corp
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Sysmex Corp
TSE:6869
Pre-Tax Income
ÂĄ79.6B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
7%
Terumo Corp
TSE:4543
Pre-Tax Income
ÂĄ159.5B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
11%
Olympus Corp
TSE:7733
Pre-Tax Income
ÂĄ42.5B
CAGR 3-Years
-25%
CAGR 5-Years
-3%
CAGR 10-Years
5%
Nihon Kohden Corp
TSE:6849
Pre-Tax Income
ÂĄ25.2B
CAGR 3-Years
-8%
CAGR 5-Years
12%
CAGR 10-Years
3%
JEOL Ltd
TSE:6951
Pre-Tax Income
ÂĄ33.3B
CAGR 3-Years
65%
CAGR 5-Years
34%
CAGR 10-Years
21%
Fukuda Denshi Co Ltd
TSE:6960
Pre-Tax Income
ÂĄ26.4B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
8%
No Stocks Found

Sysmex Corp
Glance View

Market Cap
2T JPY
Industry
Health Care

Sysmex Corporation, a global leader in healthcare and diagnostics, specializes in innovative laboratory solutions and instruments that enhance patient care and streamline clinical workflows. Established in 1968 and headquartered in Kobe, Japan, Sysmex has evolved from a domestic player to an international powerhouse, with a presence in over 190 countries. With a steadfast commitment to research and development, the company focuses on hematology, immunochemistry, and molecular diagnostics, continually pushing the boundaries of technology. Their flagship products, which include advanced analyzers and systems, empower healthcare professionals to make timely and accurate clinical decisions, ultimately improving patient outcomes across the globe. For investors, Sysmex embodies a compelling growth story in the ever-expanding healthcare market. The aging population and increasing prevalence of chronic diseases drive demand for diagnostic solutions, positioning Sysmex to capitalize on these trends. The company’s robust financial performance is evidenced by consistent revenue growth and a strong balance sheet, supported by strategic collaborations and a diverse product portfolio. With a commitment to sustainability and social responsibility, Sysmex not only prioritizes profitability but also aims to contribute positively to global health challenges. As the world increasingly relies on advanced diagnostics, Sysmex stands out as a forward-thinking investment opportunity that combines financial stability with a meaningful social impact.

Intrinsic Value
2 973.08 JPY
Overvaluation 6%
Intrinsic Value
Price

See Also

What is Sysmex Corp's Pre-Tax Income?
Pre-Tax Income
79.6B JPY

Based on the financial report for Sep 30, 2024, Sysmex Corp's Pre-Tax Income amounts to 79.6B JPY.

What is Sysmex Corp's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
7%

Over the last year, the Pre-Tax Income growth was 18%. The average annual Pre-Tax Income growth rates for Sysmex Corp have been 10% over the past three years , 7% over the past five years , and 7% over the past ten years .

Back to Top